Analysen von Keyur Parekh
09.02.22 | Merck Sell | Goldman Sachs Group Inc. | |
04.02.22 | Sanofi Buy | Goldman Sachs Group Inc. | |
03.02.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
02.02.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
02.02.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
27.01.22 | Sanofi Buy | Goldman Sachs Group Inc. | |
26.01.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
26.01.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
Werbung
|
|||
25.01.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
07.01.22 | GSK Buy | Goldman Sachs Group Inc. | |
23.12.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
16.12.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
16.12.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
16.12.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
14.12.21 | GSK Buy | Goldman Sachs Group Inc. | |
10.12.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
07.12.21 | GSK Buy | Goldman Sachs Group Inc. | |
22.11.21 | Merck Sell | Goldman Sachs Group Inc. | |
22.11.21 | Bayer Buy | Goldman Sachs Group Inc. | |
18.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
12.11.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
11.11.21 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
11.11.21 | Sanofi Buy | Goldman Sachs Group Inc. | |
11.11.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
11.11.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
11.11.21 | GSK Buy | Goldman Sachs Group Inc. | |
11.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
09.11.21 | Bayer Buy | Goldman Sachs Group Inc. | |
08.11.21 | GSK Buy | Goldman Sachs Group Inc. | |
04.11.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
04.11.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
04.11.21 | Merck Sell | Goldman Sachs Group Inc. | |
03.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
02.11.21 | Merck Sell | Goldman Sachs Group Inc. | |
02.11.21 | Bayer Buy | Goldman Sachs Group Inc. | |
01.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
29.10.21 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
28.10.21 | Sanofi Buy | Goldman Sachs Group Inc. | |
27.10.21 | GSK Buy | Goldman Sachs Group Inc. | |
26.10.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
25.10.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
20.10.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
14.10.21 | GSK Buy | Goldman Sachs Group Inc. | |
14.10.21 | Sanofi Buy | Goldman Sachs Group Inc. | |
14.10.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
14.10.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
14.10.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
11.10.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
23.09.21 | Bayer Buy | Goldman Sachs Group Inc. | |
21.09.21 | Merck Sell | Goldman Sachs Group Inc. |